Thursday, Intuitive Surgical (NASDAQ: ISRG) reported its second-quarter results after market close.
The company disclosed that its earnings per share for the quarter were $2.80, compared to $2.19 a year earlier. Analysts had anticipated earnings of $2.50 per share.
Intuitive Surgical recorded revenue of $2.89 billion for the quarter, surpassing analyst expectations of $2.82 billion and exceeding the $2.44 billion reported a year earlier.
Instruments and accessories revenue for the second quarter increased by 18 percent to $1.73 billion. Systems revenue for the same period was $685 million, up from $575 million in the second quarter of the previous year.
For the full year of 2026, the company expects worldwide da Vinci procedure growth of approximately 13.5 percent to 15.5 percent, with expectations to be closer to the midpoint of this range.
Non-GAAP gross profit margin for the full year is projected to be within a range of 68.0 percent to 69.0 percent of revenue, including an estimated impact from tariffs of 1.0 percent of revenue. Non-GAAP operating expense growth is expected to be between 11 percent and 13 percent.
The company ended the second quarter with $8.63 billion in cash, cash equivalents, and investments.
In after-hours trading, Intuitive Surgical is down 10.92 percent to a price of 358.40, representing a decline of 43.93 from its end-of-day price of 402.33. The company’s shares are currently trading within a 52-week range of 378.50 to 603.88.
